Merck to Present New Data on Investigational Chronic Hepatitis C Treatment

Merck to Present New Data on Investigational Chronic Hepatitis C Treatment
KENILWORTH, N.J., Oct 20, 2015 (BUSINESS WIRE) — Merck MRK, +1.67% known as MSD outside the United States and Canada, today announced that new data from clinical trials of its investigational treatment portfolio for chronic hepatitis C virus (HCV) …
Read more here.

Patients Using AbbVie's Hepatitis C Treatments Can Suffer Potential Risk of
The US Food and Drug Administration (FDA) issued a warning about AbbVie Inc.'s new hepatitis C treatments saying the drugs might cause serious liver injury in patients with underlying liver disease. The FDA released a statement saying that it had …
Read more here.

How insurance providers deny hepatitis C patients lifesaving drugs
Amber Rojas was almost eight months pregnant when she learned she had hepatitis C. After her daughter was born on Dec. 23, 2014, Rojas had hoped to start treatment with a newly approved, highly effective drug called Harvoni. After filing for prior …
Read more here.

One senator's push to fund hepatitis C treatment for veterans
Mark Kirk (R-Ill.) and approved a budget for the Department of Veterans Affairs (VA) that included an additional $ 200 million to fund critical hepatitis C treatments for a total of more than $ 1.5 billion for hepatitis C over the next two years. The …
Read more here.

FDA adds liver warning to AbbVie hepatitis C drugs
AbbVie's drugs are part of a new wave of pill-only combinations that cure more patients and cause fewer side effects than older hepatitis C treatments, which required injections and caused flu-like side effects. Gilead Sciences initially dominated the …
Read more here.


Leave a Reply